Keywords
Cytomegalovirus,, kidney transplantation, UL97 mutation, antiviral resistance, letermovir
Abstract
Infection with cytomegalovirus (CMV) with resistance to ganciclovir (GCV) is a therapeutic challenge in kidney transplant patients, because standard treatment options are nephrotoxic. We report the case of a kidney transplant recipient with GCV-resistant CMV disease, in whom letermovir, a novel inhibitor of CMV packaging, was administered off-label and prevented a relapse of disease once the CMV load was decreased by cidofovir. Furthermore, we observed significant drug interactions between letermovir and tacrolimus.
References
![](https://www.ejcrim.com/public/journals/1/article_1622_cover_en_US.jpg)
Views: 1279
HTML downloads: 187
PDF downloads: 663
Published:
2020-04-20
Issue:
2020: Vol 7 No 7
(view)